Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

Presentation TCT 2017

PLLA-Based Biolimus A9 Elution I: Outcomes With the BioMatrix Family of DES

Presenter: Ioannis Iakovou, Gert Richardt, Christophe Dubois

October 30, 2017

News Conference News TCT 2016

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: BioMatrix Biolimus-Eluting Stents

Presenter: Dean J. Kereiakes, Pieter C. Smits, Stephan Windecker

October 30, 2016

News Conference News TCT 2015

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

October 13, 2015

Presentation TCT 2015

Update on Biolimus-Eluting Stent Platforms: BioMatrix and Nobori Program Update

Presenter: Stephen G. Ellis, John A. Ormiston, Philip M. Urban

October 11, 2015

News Conference News TCT 2014

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

September 17, 2014

Presentation TCT 2014

2-year outcomes and angiograms from the bifurcation subgroup of the e-BioMatrix registry

Presenter: Keith Oldroyd

September 16, 2014

Presentation TCT 2014

Safety and Efficacy Profile of BioMatrix and Nobori in Simple and Complex Lesions: Global Program Overview

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stephan Windecker

September 15, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

News Conference News TCT 2014

OCT STEMI: Imaging-Guided PCI Shows Promise

September 14, 2014

News Conference News TCT 2013

SORT-OUT VI: Permanent Polymer ZES Noninferior to Biodegradable BES in All-Comers Study

October 30, 2013

Presentation TCT 2013

TCT-16. Incidence, mechanisms and outcome of longitudinal stent deformation (LSD) associated with Element, Resolute, Biomatrix and Xience stents: angiographic and case-by-case...

Presenter: Samer Arnous

October 29, 2013

Presentation TCT 2013

Synthesis of Clinical Trials with the Biomatrix Stent

Presenter: Stephan Windecker

October 28, 2013

News Conference News TCT 2013

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

October 28, 2013

News Conference News TCT 2012

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

November 02, 2012

Advertisement

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

PLLA-Based Biolimus A9 Elution I: Outcomes With the BioMatrix Family of DES

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Stent Design and Comprehensive Data Review: BioMatrix Biolimus-Eluting Stents

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

Update on Biolimus-Eluting Stent Platforms: BioMatrix and Nobori Program Update

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

2-year outcomes and angiograms from the bifurcation subgroup of the e-BioMatrix registry

Safety and Efficacy Profile of BioMatrix and Nobori in Simple and Complex Lesions: Global Program Overview

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

OCT STEMI: Imaging-Guided PCI Shows Promise

SORT-OUT VI: Permanent Polymer ZES Noninferior to Biodegradable BES in All-Comers Study

TCT-16. Incidence, mechanisms and outcome of longitudinal stent deformation (LSD) associated with Element, Resolute, Biomatrix and Xience stents: angiographic and case-by-case...

Synthesis of Clinical Trials with the Biomatrix Stent

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content